Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

[Full Text]
Displaying Investigations 1 to 48 of 48 found
From 1 References


Kandoth et al 2013, Nature
  Adenocarcinoma Uterus, corpus
NCOA3/EYA2
dup(20)(q13q13)
  Adenocarcinoma Uterus, corpus
ARL3/ACO1
t(9;10)(p21;q24)
  Adenocarcinoma Uterus, corpus
GDA/EPS8L2
t(9;11)(q21;p15)
  Adenocarcinoma Uterus, corpus
SCNN1A/LPAR5
dup(12)(p13p13)
  Adenocarcinoma Uterus, corpus
SSU72/ASCC1
t(1;10)(p36;q22)
  Adenocarcinoma Uterus, corpus
FMNL2/GPBAR1
del(2)(q23q35)
  Adenocarcinoma Uterus, corpus
ZNF3/ACTL6B
dup(7)(q22q22)
  Adenocarcinoma Uterus, corpus
MTMR3/GJB1
t(X;22)(q13;q12)
  Adenocarcinoma Uterus, corpus
NFAT5/SNTB2
dup(16)(q22q22)
  Adenocarcinoma Uterus, corpus
EYA2/SLC2A10
dup(20)(q13q13)
  Adenocarcinoma Uterus, corpus
KDM4A/PNKD
t(1;2)(p34;q35)
  Adenocarcinoma Uterus, corpus
NPLOC4/SIRT7
dup(17)(q25q25)
  Adenocarcinoma Uterus, corpus
KIAA0100/MYO18A
dup(17)(q11q11)
  Adenocarcinoma Uterus, corpus
MICALL1/IFT122
t(3;22)(q21;q13)
  Adenocarcinoma Uterus, corpus
PUM1/NKAIN1
dup(1)(p35p35)
  Adenocarcinoma Uterus, corpus
UNK/MYO15B
dup(17)(q25q25)
  Adenocarcinoma Uterus, corpus
CSNK1D/POLR2E
t(17;19)(q25;p13)
  Adenocarcinoma Uterus, corpus
DOT1L/CSNK1G2
dup(19)(p13p13)
  Adenocarcinoma Uterus, corpus
GALNT14/BRE
inv(2)(p23p23)
  Adenocarcinoma Uterus, corpus
SLC25A13/SHFM1
dup(7)(q21q21)
  Adenocarcinoma Uterus, corpus
TANC1/SLC4A1AP
t(2;2)(p23;q24)
  Adenocarcinoma Uterus, corpus
GADD45GIP1/CSTF1
t(19;20)(p13;q13)
  Adenocarcinoma Uterus, corpus
PSMD3/CDK12
dup(17)(q12q21)
  Adenocarcinoma Uterus, corpus
CDK12/EIF4A3
inv(17)(q12q25)
  Adenocarcinoma Uterus, corpus
NSUN5/BCL7B
dup(7)(q11q11)
  Adenocarcinoma Uterus, corpus
BCL9/RASAL2
del(1)(q21q25)
  Adenocarcinoma Uterus, corpus
ERBB2/TSPAN11
t(12;17)(p11;q12)
  Adenocarcinoma Uterus, corpus
PIK3CA/KCNMB3
inv(3)(q26q26)
  Adenocarcinoma Uterus, corpus
SRP68/MIEN1
del(17)(q12q25)
  Adenocarcinoma Uterus, corpus
DDI2/EFHD2
dup(1)(p36p36)
  Adenocarcinoma Uterus, corpus
LRIG1/SLC25A26
inv(3)(p14p14)
  Adenocarcinoma Uterus, corpus
DNAJC1/SFTPD
t(10;10)(p12;q22)
  Adenocarcinoma Uterus, corpus
CSNK1E/SPATA21
t(1;22)(p36;q13)
  Adenocarcinoma Uterus, corpus
MTMR3/HEXIM2
t(17;22)(q21;q12)
  Adenocarcinoma Uterus, corpus
CSNK1E/DYNLRB1
t(20;22)(q11;q13)
  Adenocarcinoma Uterus, corpus
ZNF704/GFER
t(8;16)(q21;p13)
  Adenocarcinoma Uterus, corpus
DLG4/SHBG
inv(17)(p13p13)
  Adenocarcinoma Uterus, corpus
QRICH1/SHISA5
del(3)(p21p21)
  Adenocarcinoma Uterus, corpus
CPNE2/NUP93
dup(16)(q13q13)
  Adenocarcinoma Uterus, corpus
POLR2B/FIP1L1
dup(4)(q12q12)
  Adenocarcinoma Uterus, corpus
AACS/MAL
t(2;12)(q11;q24)
  Adenocarcinoma Uterus, corpus
BICD1/METTL20
dup(12)(p11p11)
  Adenocarcinoma Uterus, corpus
CTTN/ANO1
dup(11)(q13q13)
  Adenocarcinoma Uterus, corpus
TRHDE/LGR5
dup(12)(q21q21)
  Adenocarcinoma Uterus, corpus
CELSR1/KCNJ4
del(22)(q13q13)
  Adenocarcinoma Uterus, corpus
ITCH/RALY
dup(20)(q11q11)
  Adenocarcinoma Uterus, corpus
KIF26A/CKB
inv(14)(q32q32)
  Adenocarcinoma Uterus, corpus
ODF2/SLC27A4
dup(9)(q34q34)